Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report

article published in 2018

Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report is …
instance of (P31):
case reportQ2782326
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1110028793
P356DOI10.1186/S40360-018-0267-5
P932PMC publication ID6245888
P698PubMed publication ID30454022

P50authorTrygve HolmøyQ64539783
P2093author name stringGisle Bjerke
Svetozar Zarnovicky
Aija Zuleron Myro
P2860cites workDiffuse alveolar hemorrhageQ84155719
Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for useQ26849781
Bicuspid Aortic Valve: a Review with Recommendations for Genetic CounselingQ28080091
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trialQ30053056
Drug-induced diffuse alveolar hemorrhage syndromes and vasculitisQ35737068
Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosisQ37337775
Monoclonal antibody-induced cytokine-release syndromeQ37755276
Acute infusion reactions induced by monoclonal antibody therapyQ37821495
Pulmonary toxicities from targeted therapies: a reviewQ37955066
The immunological function of CD52 and its targeting in organ transplantationQ38747419
Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS.Q39744600
Diffuse Alveolar haemorrhage: a fatal complication after alemtuzumab induction therapy in renal transplantation.Q40171238
Acute pneumonitis and pericarditis related to alemtuzumab therapy in relapsing-remitting multiple sclerosisQ48196935
Diffuse alveolar hemorrhage following alemtuzumabQ48431558
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectmultiple sclerosisQ8277
diffuse alveolar hemorrhageQ55788710
P304page(s)75
P577publication date2018-11-19
P1433published inBMC pharmacology & toxicologyQ27724429
P1476titleDiffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report
P478volume19

Reverse relations

cites work (P2860)
Q92572779Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis
Q99615731Alemtuzumab-associated diffuse alveolar damage - a case report

Search more.